EP 0833656 A2 19980408 - PHARMACEUTICAL COMPOSITIONS COMPRISING RESTRICTIN P/ACTIVIN A AND USE THEREOF AS ANTAGONIST OF IL-6 AND/OR IL-11
Title (en)
PHARMACEUTICAL COMPOSITIONS COMPRISING RESTRICTIN P/ACTIVIN A AND USE THEREOF AS ANTAGONIST OF IL-6 AND/OR IL-11
Title (de)
RESTRICTINE P/ACTIVINE A ENTHALTENDE PHARMAZEUTISCHE ZUSAMMENSETZUNGEN UND IHRE VERWENDUNG ALS IL-6 ODER/UND IL-11 ANTAGONISTEN
Title (fr)
COMPOSITIONS PARMACEUTIQUES COMPRENANT DE LA RESTRICTINE P/ACTIVINE A, ET LEUR UTILISATION EN QUALITE D'ANTAGONISTES DE IL-6 ET/OU IL-11
Publication
Application
Priority
- IL 9600008 W 19960609
- IL 11407795 A 19950609
- IL 11626095 A 19951206
Abstract (en)
[origin: WO9641607A2] The pleiotropic cytokine restrictin P/activin A modulates the in vivo activity of IL-6 and/or IL-11 and can be used for the preparation of pharmaceutical compositions useful, for example, for blocking or reducing the deleterious effects of IL-6, e.g. in patients being treated with IL-6 while undergoing tumor therapy or bone marrow transplantation.
IPC 1-7
IPC 8 full level
C12N 15/09 (2006.01); A61K 38/00 (2006.01); A61K 38/22 (2006.01); A61P 37/00 (2006.01); C07K 14/575 (2006.01)
CPC (source: EP)
A61P 37/00 (2017.12); C07K 14/575 (2013.01); A61K 38/00 (2013.01)
Designated contracting state (EPC)
AT BE CH DE DK ES FI FR GB GR IE IT LI LU MC NL PT SE
DOCDB simple family (publication)
WO 9641607 A2 19961227; WO 9641607 A3 19970130; EP 0833656 A2 19980408; EP 0833656 A4 19990203; JP H11507663 A 19990706
DOCDB simple family (application)
IL 9600008 W 19960609; EP 96917638 A 19960609; JP 50286897 A 19960609